iRhythm Holdings, Inc. · Exercise / conversion · Common Stock

What does this filing report?

An SEC Form 4 filing for iRhythm Holdings, Inc. records an exercise / conversion involving Common Stock on November 10, 2025. The reported quantity was 5,312. The filing date is November 12, 2025. This is one transaction record; amounts are not allocated among any joint reporting owners.

The acquisition category describes how securities were received. It does not by itself establish a cash purchase of common stock. Read the transaction code definitionsand the original filing before interpreting the amounts.

Filing footnotes & remarks

F1

All transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan established by Mr. Talwalkar on May 12, 2025.

F2

Represents the weighted-average sale price per share of a series of transactions, all of which were executed on November 10, 2025. The actual sale prices ranged from a low of $171.7350 to a high of $172.7000, inclusive. Mr. Talwalkar undertakes to provide upon request of the SEC staff, iRhythm Technologies, Inc. or any security holder of iRhythm Technologies, Inc., full information regarding the numbers of shares sold at each price within the range. The weighted-average sale price reflected has been rounded to 4 decimal points.

F3

Represents the weighted-average sale price per share of a series of transactions, all of which were executed on November 10, 2025. The actual sale prices ranged from a low of $172.7450 to a high of $172.9600, inclusive. Mr. Talwalkar undertakes to provide upon request of the SEC staff, iRhythm Technologies, Inc. or any security holder of iRhythm Technologies, Inc., full information regarding the numbers of shares sold at each price within the range. The weighted-average sale price reflected has been rounded to 4 decimal points.

F4

Represents the weighted-average sale price per share of a series of transactions, all of which were executed on November 10, 2025. The actual sale prices ranged from a low of $173.8700 to a high of $174.7000 inclusive. Mr. Talwalkar undertakes to provide upon request of the SEC staff, iRhythm Technologies, Inc. or any security holder of iRhythm Technologies, Inc., full information regarding the numbers of shares sold at each price within the range. The weighted-average sale price reflected has been rounded to 4 decimal points.

F5

Represents the weighted-average sale price per share of a series of transactions, all of which were executed on November 10, 2025. The actual sale prices ranged from a low of $174.7500 to a high of $175.2800, inclusive. Mr. Talwalkar undertakes to provide upon request of the SEC staff, iRhythm Technologies, Inc. or any security holder of iRhythm Technologies, Inc., full information regarding the numbers of shares sold at each price within the range. The weighted-average sale price reflected has been rounded to 4 decimal points.

F6

Represents the weighted-average sale price per share of a series of transactions, all of which were executed on November 10, 2025. The actual sale prices ranged from a low of $175.7650 to a high of $176.1150, inclusive. Mr. Talwalkar undertakes to provide upon request of the SEC staff, iRhythm Technologies, Inc. or any security holder of iRhythm Technologies, Inc., full information regarding the numbers of shares sold at each price within the range. The weighted-average sale price reflected has been rounded to 4 decimal points.

F7

The option, originally granted on May 23, 2016 for 21,248 shares, vested in thirty-six equal monthly installments. This option has an expiration date of May 23, 2026. The Rule 10b5-1 trading plan of Mr. Talwalkar solely covers shares subject to options expiring in 2026 and 2027.

Footnotes are reproduced as plain text from the current source filing. For the full context, read the original SEC filing.